Alexis A. Thompson - Mar 17, 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc. (GBT)

Role
Director
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Stock symbol
GBT
Transactions as of
Mar 17, 2022
Transactions value $
$0
Form type
4
Date filed
3/18/2022, 06:58 PM
Previous filing
Jun 21, 2021
Next filing
Jun 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Options Exercise +2.4K 2.4K Mar 17, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Restricted Stock Units Options Exercise $0 -2.4K -33.33% $0.00 4.8K Mar 17, 2022 Common Stock 2.4K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2 The shares of Common Stock underlying the RSUs vest in three equal annual installments after March 17, 2021, so long as the Reporting Person continues as a board member of the Issuer through each vesting date. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended).